XML 54 R43.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Equity Awards and Instruments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract] |
Schedule of Stock-based Compensation Expense | Total stock‑based compensation expense consists of the following:
| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Restricted stock and restricted stock units (“RSUs”) expense (1) | $ | 10,441 |  |  | $ | 4,681 |  |  | $ | 25,003 |  |  | $ | 11,139 |
Bonus Plan expense (see Note 11) | 7,305 |  |  | 5,586 |  |  | 21,444 |  |  | 17,181 |
ESPP expense (see Note 13) | 565 |  |  | 539 |  |  | 2,394 |  |  | 1,416 |
Stock option expense | 395 |  |  | 773 |  |  | 1,762 |  |  | 2,494 |
Stock grants expense | — |  |  | — |  |  | 450 |  |  | 450 |
DCP elective participant deferrals expense (2) (see Note 12) | 85 |  |  | 173 |  |  | 306 |  |  | 173 |
Total stock-based compensation expense (3) | $ | 18,791 |  |  | $ | 11,752 |  |  | $ | 51,359 |  |  | $ | 32,853 |
(1)Includes acquisition‑related shares (see Note 4). (2)DCP elective participant deferrals expense excludes deferred incentive bonus payable pursuant to the Bonus Plan. (3)As of September 30, 2022 and December 31, 2021, $7,382 and $6,749 remained in Accruals and other current liabilities in the consolidated balance sheets, respectively. Total stock‑based compensation expense is included in the consolidated statements of operations as follows:
| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Cost of subscriptions and licenses | $ | 757 |  |  | $ | 323 |  |  | $ | 1,927 |  |  | $ | 822 |
Cost of services | 460 |  |  | 235 |  |  | 1,407 |  |  | 685 |
Research and development | 6,754 |  |  | 5,227 |  |  | 17,693 |  |  | 14,069 |
Selling and marketing | 2,014 |  |  | 1,582 |  |  | 5,657 |  |  | 3,885 |
General and administrative | 8,806 |  |  | 4,385 |  |  | 24,675 |  |  | 13,392 |
Total stock-based compensation expense | $ | 18,791 |  |  | $ | 11,752 |  |  | $ | 51,359 |  |  | $ | 32,853 |
Schedule of Options | The following is a summary of stock option activity and related information under the Company’s applicable equity incentive plans:
|  |  |  |  | Weighted |  |
|  |  | Weighted |  | Average |  |
|  |  | Average |  | Remaining |  | Aggregate
| Stock |  | Exercise Price |  | Contractual |  | Intrinsic
| Options |  | Per Share |  | Life (in years) |  | Value
Outstanding, December 31, 2021 | 6,917,925 |  |  | $ | 5.26 |  |  |  |  |
Exercised | (2,635,429) |  |  | 4.77 |  |  |  |  |
Forfeited and expired | (105,500) |  |  | 5.64 |  |  |  |  |
Outstanding, September 30, 2022 | 4,176,996 |  |  | $ | 5.56 |  |  | 1.1 |  | $ | 104,542 |
Exercisable, September 30, 2022 | 3,225,496 |  |  | $ | 5.51 |  |  | 1.0 |  | $ | 80,897 |
Schedule of Restricted Stock and Restricted Stock Unit Activity | The following is a summary of unvested restricted stock and RSU activity and related information under the Company’s applicable equity incentive plans:
|  |  |  |  |  |  | Time- |  | Performance-
|  |  |  |  |  |  | Based |  | Based
|  |  | Time- |  | Performance- |  | Weighted |  | Weighted
| Total |  | Based |  | Based |  | Average |  | Average
| Restricted |  | Restricted |  | Restricted |  | Grant Date |  | Grant Date
| Stock |  | Stock |  | Stock |  | Fair Value |  | Fair Value
| and RSUs |  | and RSUs |  | and RSUs |  | Per Share |  | Per Share
Unvested, December 31, 2021 | 1,708,545 |  |  | 1,611,862 |  |  | 96,683 |  | (4) | $ | 32.81 |  |  | $ | 49.93 |
Granted | 1,598,661 |  | (1) | 1,235,888 |  | (3) | 362,773 |  | (5) | 38.82 |  | 38.21
Vested | (477,283) |  |  | (386,113) |  |  | (91,170) |  | (4) | 26.40 |  |  | 49.93 |
Forfeited and canceled | (147,816) |  |  | (142,303) |  |  | (5,513) |  |  | 33.64 |  |  | 49.93 |
Unvested, September 30, 2022 | 2,682,107 |  | (2) | 2,319,334 |  |  | 362,773 |  |  | 37.02 |  |  | 38.21 |
(1)For the nine months ended September 30, 2022, the Company only granted RSUs. (2)Includes 50,917 RSUs which are expected to be settled in cash. (3)Includes 199,076 time‑based RSUs granted during the three months ended March 31, 2022 to certain officers and key employees, which cliff vest on January 31, 2025. (4)Relates to the 2021 annual performance period. Total stock‑based compensation expense associated with these awards was fully recognized as of December 31, 2021. (5)Primarily relates to the 2022 annual performance period, except for 185,186 performance‑based RSUs granted during the three months ended March 31, 2022 with extraordinary terms, which are described below.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration